KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to -$719.0 million.

  • Bausch Health Companies' Cash from Financing Activities fell 28042.33% to -$719.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$422.0 million, marking a year-over-year increase of 5910.85%. This contributed to the annual value of -$868.0 million for FY2024, which is 15884.75% down from last year.
  • Per Bausch Health Companies' latest filing, its Cash from Financing Activities stood at -$719.0 million for Q3 2025, which was down 28042.33% from $358.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cash from Financing Activities registered a high of $1.8 billion during Q3 2023, and its lowest value of -$1.2 billion during Q3 2021.
  • For the 5-year period, Bausch Health Companies' Cash from Financing Activities averaged around -$99.3 million, with its median value being -$146.0 million (2025).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 88888.89% in 2021, then soared by 514444.44% in 2023.
  • Quarter analysis of 5 years shows Bausch Health Companies' Cash from Financing Activities stood at $275.0 million in 2021, then crashed by 200.36% to -$276.0 million in 2022, then surged by 71.38% to -$79.0 million in 2023, then skyrocketed by 207.59% to $85.0 million in 2024, then plummeted by 945.88% to -$719.0 million in 2025.
  • Its Cash from Financing Activities was -$719.0 million in Q3 2025, compared to $358.0 million in Q2 2025 and -$146.0 million in Q1 2025.